Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method for assessing risk of cutaneous adverse drug reactions caused by epidermal growth factor receptor inhibitors, detection kit thereof, and use thereof

Method for assessing risk of cutaneous adverse drug reactions caused by epidermal growth factor receptor inhibitors, detection kit thereof, and use thereof

US Patent 12467090 · Granted Nov 11, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Replaceable frame assembly for accommodating expansion card module and electroni2024
Modular replaceable mobile communication device2023
Methods and apparatus for treating a wound2021
Method for evaluating the risk of drug hypersensitivity reaction induced by Sulf2021
Risk assessment for phenytoin-induced adverse drug reactions2021
Child bicycle seat2017
Circuit for monitoring metal degradation on integrated circuit2017
Risk assessment for adverse drug reactions2017
Compositions containing berberine or analogs thereof for treating rosacea or red2016
Monitoring system for detecting degradation of integrated circuit2015
Method of designing integrated circuit that accounts for device aging2013
Granulysin and uses thereof2013